ARALEZ PHARMACEUTICALS INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
ARALEZ PHARMACEUTICALS INC. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $10.49 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-05-09
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was $10.49M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was -$15.07M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was -$10.94M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-06-30 was -$16.41M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$83.73M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$16.79M, a 4687.16% decline from fiscal 2014.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was $366.00K.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | $10.49M 10-Q · filed 2017-05-09 | -$4.58M derived: sum of 2 quarters · filed 2017-05-09 | -$15.52M derived: sum of 3 quarters · filed 2017-05-09 | -$31.93M derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | -$15.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$26.01M derived: sum of 2 quarters · filed 2017-03-13 | -$42.42M derived: sum of 3 quarters · filed 2017-03-13 | -$83.73M 10-K · filed 2017-03-13 |
| 2016-09-30 | -$10.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$27.35M derived: sum of 2 quarters · filed 2016-11-08 | -$68.66M 10-Q · filed 2016-11-08 | -$78.30M derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-06-30 | -$16.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$57.72M 10-Q · filed 2016-08-09 | -$67.36M derived: sum of 3 quarters · filed 2017-05-09 | -$72.06M derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-03-31 | -$41.31M 10-Q · filed 2017-05-09 | -$50.95M derived: sum of 2 quarters · filed 2017-05-09 | -$55.64M derived: sum of 3 quarters · filed 2017-05-09 | -$58.83M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | -$9.64M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$14.33M derived: sum of 2 quarters · filed 2017-03-13 | -$17.52M derived: sum of 3 quarters · filed 2017-03-13 | -$16.79M 10-K · filed 2017-03-13 |
| 2015-09-30 | -$4.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$7.88M derived: sum of 2 quarters · filed 2016-11-08 | -$7.15M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | -$3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$2.46M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $732.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $366.00K 10-K · filed 2017-03-13 |